GLECKEL LOUIS MD 4
4 · ProPhase Labs, Inc. · Filed Aug 17, 2020
Insider Transaction Report
Form 4
GLECKEL LOUIS MD
10% Owner
Transactions
- Purchase
Common Stock, par value $0.0005
2020-08-13$2.75/sh+50,000$137,500→ 273,840 total
Footnotes (1)
- [F1]These shares were purchased in a private transaction from Ted Karkus, Chairman and Chief Executive Officer of the Issuer, pursuant to the terms of a Stock Purchase Agreement